Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chunli Liu

Showing results (311-320 of 322) with videos related to

Pageof 33
Sort By:
British Journal of Pharmacology|November 3, 2020
Mitomycin C induces pulmonary vascular endothelial-to-mesenchymal transition and pulmonary veno-occlusive disease via Smad3-dependent pathway in ratsChenting Zhang, Wenju Lu, Xiaoyun Luo, et al.
Biochemical Pharmacology|March 11, 2022
Sodium tanshinone IIA sulfonate enhances the BMP9-BMPR2-Smad1/5/9 signaling pathway in rat pulmonary microvascular endothelial cells and human embryonic stem cell-derived endothelial cellsJian Wang, Wenyan Liu, Wenju Lu, et al.
Journal of Ethnopharmacology|November 11, 2021
Efficacy and safety of Bufei Huoxue capsules in the management of convalescent patients with COVID-19 infection: A multicentre, double-blind, and randomised controlled trialYuqin Chen, Chunli Liu, Tingping Wang, et al.
BMC Medicine|March 10, 2025
Distinct airway mycobiome signature in patients with pulmonary hypertension and subgroupsChenting Zhang, Bihua Zhong, Qian Jiang, et al.
Pulmonary Circulation|April 28, 2025
A Subgroup Reanalysis of the Efficacy of Bufei Huoxue Capsules in Patients With "Long-Covid-19"Chi Hou, Yue Xing, Yuqin Chen, et al.
Respiratory Research|January 7, 2023
Correction to: Prediction and prognosis of adverse maternal and foetal/neonatal outcomes in pulmonary hypertension: an observational study and nomogram constructionYuqin Chen, Dansha Zhou, Mingmei Xiong, et al.
Respiratory Research|November 15, 2022
Prediction and prognosis of adverse maternal and foetal/neonatal outcomes in pulmonary hypertension: an observational study and nomogram constructionYuqin Chen, Dansha Zhou, Mingmei Xiong, et al.
Respiratory Research|July 30, 2024
Nephrectomy and high-salt diet inducing pulmonary hypertension and kidney damage by increasing Ang II concentration in ratsQian Jiang, Qifeng Yang, Chenting Zhang, et al.
Clinical and Translational Medicine|June 11, 2024
Prediction of clinical risk assessment and survival in chronic obstructive pulmonary disease with pulmonary hypertensionDansha Zhou, Chunli Liu, Lan Wang, et al.
American Journal of Respiratory and Critical Care Medicine|June 6, 2025
Deficient FANCL Predisposes to Endothelial Damage: A New Therapeutic Target for Pulmonary HypertensionShiyun Liu, Xiaoqian Shan, Yufei Sun, et al.
Pageof 33

Showing results (311-320 of 322) with videos related to

Sort By:
Pageof 33
British Journal of Pharmacology|November 3, 2020
Mitomycin C induces pulmonary vascular endothelial-to-mesenchymal transition and pulmonary veno-occlusive disease via Smad3-dependent pathway in ratsChenting Zhang, Wenju Lu, Xiaoyun Luo, et al.
Biochemical Pharmacology|March 11, 2022
Sodium tanshinone IIA sulfonate enhances the BMP9-BMPR2-Smad1/5/9 signaling pathway in rat pulmonary microvascular endothelial cells and human embryonic stem cell-derived endothelial cellsJian Wang, Wenyan Liu, Wenju Lu, et al.
Journal of Ethnopharmacology|November 11, 2021
Efficacy and safety of Bufei Huoxue capsules in the management of convalescent patients with COVID-19 infection: A multicentre, double-blind, and randomised controlled trialYuqin Chen, Chunli Liu, Tingping Wang, et al.
BMC Medicine|March 10, 2025
Distinct airway mycobiome signature in patients with pulmonary hypertension and subgroupsChenting Zhang, Bihua Zhong, Qian Jiang, et al.
Pulmonary Circulation|April 28, 2025
A Subgroup Reanalysis of the Efficacy of Bufei Huoxue Capsules in Patients With "Long-Covid-19"Chi Hou, Yue Xing, Yuqin Chen, et al.
Respiratory Research|January 7, 2023
Correction to: Prediction and prognosis of adverse maternal and foetal/neonatal outcomes in pulmonary hypertension: an observational study and nomogram constructionYuqin Chen, Dansha Zhou, Mingmei Xiong, et al.
Respiratory Research|November 15, 2022
Prediction and prognosis of adverse maternal and foetal/neonatal outcomes in pulmonary hypertension: an observational study and nomogram constructionYuqin Chen, Dansha Zhou, Mingmei Xiong, et al.
Respiratory Research|July 30, 2024
Nephrectomy and high-salt diet inducing pulmonary hypertension and kidney damage by increasing Ang II concentration in ratsQian Jiang, Qifeng Yang, Chenting Zhang, et al.
Clinical and Translational Medicine|June 11, 2024
Prediction of clinical risk assessment and survival in chronic obstructive pulmonary disease with pulmonary hypertensionDansha Zhou, Chunli Liu, Lan Wang, et al.
American Journal of Respiratory and Critical Care Medicine|June 6, 2025
Deficient FANCL Predisposes to Endothelial Damage: A New Therapeutic Target for Pulmonary HypertensionShiyun Liu, Xiaoqian Shan, Yufei Sun, et al.
Pageof 33